Published in J Clin Oncol on December 23, 2013
Genomic analysis of metastatic cutaneous squamous cell carcinoma. Clin Cancer Res (2015) 0.96
Evaluation of the definitions of "high-risk" cutaneous squamous cell carcinoma using the american joint committee on cancer staging criteria and national comprehensive cancer network guidelines. J Skin Cancer (2014) 0.86
State of the science on prevention and screening to reduce melanoma incidence and mortality: The time is now. CA Cancer J Clin (2016) 0.85
Risk Factors for Cutaneous Squamous Cell Carcinoma Recurrence, Metastasis, and Disease-Specific Death: A Systematic Review and Meta-analysis. JAMA Dermatol (2016) 0.83
Squamous cell carcinoma with aggressive subclinical extension: 5-year retrospective review of diagnostic predictors. J Am Acad Dermatol (2015) 0.78
Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol (2016) 0.76
Inherited epidermolysis bullosa and squamous cell carcinoma: a systematic review of 117 cases. Orphanet J Rare Dis (2016) 0.75
Background and Current Treatment of Squamous Cell Carcinoma of the Anus. Oncol Ther (2016) 0.75
Skin cancer: Setting the stage for cutaneous SCC. Nat Rev Clin Oncol (2014) 0.75
Positive sentinel lymph node biopsy in a solid organ transplant recipient with a primary cutaneous squamous cell carcinoma of the nasal tip. JAAD Case Rep (2015) 0.75
Advances in the management of cutaneous squamous cell carcinoma. F1000Prime Rep (2014) 0.75
Loss of TGF-β signaling drives cSCC from skin stem cells - More evidence. Cell Cycle (2016) 0.75
Conception and Management of a Poorly Understood Spectrum of Dermatologic Neoplasms: Atypical Fibroxanthoma, Pleomorphic Dermal Sarcoma, and Undifferentiated Pleomorphic Sarcoma. Curr Treat Options Oncol (2017) 0.75
miR-203 and miR-205 expression patterns identify subgroups of prognosis in cutaneous squamous cell carcinoma. Br J Dermatol (2016) 0.75
Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol (2010) 8.55
Cutaneous squamous-cell carcinoma. N Engl J Med (2001) 7.31
Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol (1992) 4.13
Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol (2008) 3.71
Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. J Am Acad Dermatol (2013) 2.25
Uncertainty in the perioperative management of high-risk cutaneous squamous cell carcinoma among Mohs surgeons. Arch Dermatol (2010) 2.24
Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system. JAMA Dermatol (2013) 1.88
Mortality risk from squamous cell skin cancer. J Clin Oncol (2005) 1.74
Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study. JAMA Dermatol (2013) 1.73
Outcomes of primary cutaneous squamous cell carcinoma with perineural invasion: an 11-year cohort study. JAMA Dermatol (2013) 1.55
Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice. Laryngoscope (2005) 1.50
Sentinel lymph node biopsy in cutaneous squamous cell carcinoma: a systematic review of the English literature. Dermatol Surg (2006) 1.21
Invasive squamous cell carcinoma of the skin: defining a high-risk group. Ann Surg Oncol (2006) 1.18
Diameter of involved nerves predicts outcomes in cutaneous squamous cell carcinoma with perineural invasion: an investigator-blinded retrospective cohort study. Dermatol Surg (2009) 1.14
Cutaneous head and neck SCCs and risk of nodal metastasis - UK experience. J Craniomaxillofac Surg (2009) 1.07
Surgical monotherapy versus surgery plus adjuvant radiotherapy in high-risk cutaneous squamous cell carcinoma: a systematic review of outcomes. Dermatol Surg (2009) 1.01
The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors. J Surg Oncol (2012) 1.00
Comparison and evaluation of the current staging of cutaneous carcinomas. J Dtsch Dermatol Ges (2012) 0.93
Analysis and comparison of the 7th edition American Joint Committee on Cancer (AJCC) nodal staging system for metastatic cutaneous squamous cell carcinoma of the head and neck. Ann Surg Oncol (2012) 0.92
Identification of cells initiating human melanomas. Nature (2008) 8.28
Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol (2004) 7.02
BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma. Clin Cancer Res (2013) 4.28
Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell (2012) 4.04
Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease. Immunity (2012) 2.99
Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer. JAMA (2010) 2.93
A prospective study of telomere length and the risk of skin cancer. J Invest Dermatol (2008) 2.75
Use of tanning beds and incidence of skin cancer. J Clin Oncol (2012) 2.65
Topical calcineurin inhibitors for atopic dermatitis: balancing clinical benefit and possible risks. Arch Dermatol (2006) 2.56
Indoor tanning and non-melanoma skin cancer: systematic review and meta-analysis. BMJ (2012) 2.43
Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006. Arch Dermatol (2010) 2.29
Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. Hum Mol Genet (2011) 2.26
Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. J Am Acad Dermatol (2013) 2.25
Uncertainty in the perioperative management of high-risk cutaneous squamous cell carcinoma among Mohs surgeons. Arch Dermatol (2010) 2.24
Representativeness of participants in the cancer care outcomes research and surveillance consortium relative to the surveillance, epidemiology, and end results program. Med Care (2013) 2.22
Patients' experiences with care for lung cancer and colorectal cancer: findings from the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol (2010) 2.16
Teenage acne and cancer risk in US women: A prospective cohort study. Cancer (2015) 2.05
Sentinel lymph nodes in a swine model with melanoma: contrast-enhanced lymphatic US. Radiology (2004) 1.95
Adverse events among the elderly receiving chemotherapy for advanced non-small-cell lung cancer. J Clin Oncol (2009) 1.94
Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen. J Allergy Clin Immunol (2009) 1.91
Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system. JAMA Dermatol (2013) 1.88
A novel method for the isolation of skin resident T cells from normal and diseased human skin. J Invest Dermatol (2006) 1.86
Modulation of T-cell activation by malignant melanoma initiating cells. Cancer Res (2010) 1.83
Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study. JAMA Dermatol (2013) 1.73
Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells. J Exp Med (2008) 1.67
Cytolytic T cells induce ceramide-rich platforms in target cell membranes to initiate graft-versus-host disease. Blood (2009) 1.67
Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States. JAMA Dermatol (2013) 1.66
Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response. Biol Blood Marrow Transplant (2003) 1.62
VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth. Cancer Res (2011) 1.62
Sunlight exposure, vitamin D, and risk of non-Hodgkin lymphoma in the Nurses' Health Study. Cancer Causes Control (2011) 1.58
Outcomes of primary cutaneous squamous cell carcinoma with perineural invasion: an 11-year cohort study. JAMA Dermatol (2013) 1.55
The PASE questionnaire: pilot-testing a psoriatic arthritis screening and evaluation tool. J Am Acad Dermatol (2007) 1.52
Absence of beta7 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestine. Blood (2005) 1.51
Genome-wide association study of tanning phenotype in a population of European ancestry. J Invest Dermatol (2009) 1.50
Shorter telomeres associate with a reduced risk of melanoma development. Cancer Res (2011) 1.49
Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation. Blood (2002) 1.47
Interstitial granulomatous dermatitis in a patient with rheumatoid arthritis on etanercept. Cutis (2008) 1.46
Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3. Nat Genet (2011) 1.46
CCR2 is required for CD8-induced graft-versus-host disease. Blood (2005) 1.43
Regulation of myogenic progenitor proliferation in human fetal skeletal muscle by BMP4 and its antagonist Gremlin. J Cell Biol (2006) 1.42
Genetic variants in telomere-maintaining genes and skin cancer risk. Hum Genet (2010) 1.38
A multistep approach to improving biopsy site identification in dermatology: physician, staff, and patient roles based on a Delphi consensus. JAMA Dermatol (2014) 1.37
T cells require TRAIL for optimal graft-versus-tumor activity. Nat Med (2002) 1.35
Validity, reliability, and sensitivity-to-change properties of the psoriatic arthritis screening and evaluation questionnaire. Arch Dermatol Res (2009) 1.32
Obesity and risk of incident psoriatic arthritis in US women. Ann Rheum Dis (2012) 1.31
NOD2 regulates hematopoietic cell function during graft-versus-host disease. J Exp Med (2009) 1.30
Management of high-risk cutaneous squamous cell carcinoma. J Clin Aesthet Dermatol (2010) 1.30
Smoking and risk of incident psoriatic arthritis in US women. Ann Rheum Dis (2011) 1.28
ABO blood group and incidence of skin cancer. PLoS One (2010) 1.26
Basal-cell carcinoma incidence and associated risk factors in U.S. women and men. Am J Epidemiol (2013) 1.25
Patient perspectives on breast cancer treatment plan and summary documents in community oncology care: a pilot program. Cancer (2012) 1.25
Vaccinia virus inoculation in sites of allergic skin inflammation elicits a vigorous cutaneous IL-17 response. Proc Natl Acad Sci U S A (2009) 1.23
Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans. Hum Mol Genet (2013) 1.23
ABCB5 identifies a therapy-refractory tumor cell population in colorectal cancer patients. Cancer Res (2011) 1.23
Genome-wide association study identifies novel alleles associated with risk of cutaneous basal cell carcinoma and squamous cell carcinoma. Hum Mol Genet (2011) 1.23
Expression of the embryonic stem cell transcription factor SOX2 in human skin: relevance to melanocyte and merkel cell biology. Am J Pathol (2009) 1.22
Role of tumor necrosis factor-alpha in graft-versus-host disease and graft-versus-leukemia responses. Biol Blood Marrow Transplant (2003) 1.21
SOX2 contributes to melanoma cell invasion. Lab Invest (2011) 1.21
Peripheral blood fibrocytes: enhancement of wound healing by cell proliferation, re-epithelialization, contraction, and angiogenesis. Ann Surg (2011) 1.17
Smoking and risk of skin cancer: a prospective analysis and a meta-analysis. Int J Epidemiol (2012) 1.16
Follow-up of psoriatic arthritis mutilans patients treated with anti-TNF-alpha therapy. J Drugs Dermatol (2009) 1.14
Diameter of involved nerves predicts outcomes in cutaneous squamous cell carcinoma with perineural invasion: an investigator-blinded retrospective cohort study. Dermatol Surg (2009) 1.14
Psoriasis and risk of type 2 diabetes among women and men in the United States: a population-based cohort study. J Invest Dermatol (2011) 1.14
Histopathologic spectrum of psoriasiform skin reactions associated with tumor necrosis factor-α inhibitor therapy. A study of 16 biopsies. Am J Dermatopathol (2010) 1.13
Imiquimod enhances IFN-gamma production and effector function of T cells infiltrating human squamous cell carcinomas of the skin. J Invest Dermatol (2009) 1.13
Isolation of tumorigenic circulating melanoma cells. Biochem Biophys Res Commun (2010) 1.13
Psoriasis, psoriatic arthritis and increased risk of incident Crohn's disease in US women. Ann Rheum Dis (2012) 1.13
Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL. Blood (2011) 1.12
Novel genetic mutations in a sporadic port-wine stain. JAMA Dermatol (2014) 1.12
Genome-wide association study identifies nidogen 1 (NID1) as a susceptibility locus to cutaneous nevi and melanoma risk. Hum Mol Genet (2011) 1.10
Leukotriene B4-driven neutrophil recruitment to the skin is essential for allergic skin inflammation. Immunity (2012) 1.09
The embryonic morphogen, Nodal, is associated with channel-like structures in human malignant melanoma xenografts. J Cutan Pathol (2010) 1.09
Obesity and the incidence of skin cancer in US Caucasians. Cancer Causes Control (2012) 1.08
Rotating night shifts and risk of skin cancer in the nurses' health study. J Natl Cancer Inst (2011) 1.08
Kinetics of gene expression in murine cutaneous graft-versus-host disease. Am J Pathol (2004) 1.08
PGC-1 coactivators regulate MITF and the tanning response. Mol Cell (2012) 1.07
Importance of minor histocompatibility antigen expression by nonhematopoietic tissues in a CD4+ T cell-mediated graft-versus-host disease model. J Clin Invest (2003) 1.07
Comment on: the incidence and risk factors of metastasis for cutaneous squamous cell carcinoma--implications on the T-classification system. J Surg Oncol (2014) 1.07
Risk of a second primary cancer after non-melanoma skin cancer in white men and women: a prospective cohort study. PLoS Med (2013) 1.06
Tumor-specific T cells in human Merkel cell carcinomas: a possible role for Tregs and T-cell exhaustion in reducing T-cell responses. J Invest Dermatol (2013) 1.06
Melanoma stem cells: not rare, but well done. Lab Invest (2011) 1.06
Angiogenesis in wounds treated by microdeformational wound therapy. Ann Surg (2011) 1.05
Metastatic basal cell carcinoma of the posterior neck: case report and review of the literature. J Cutan Pathol (2012) 1.05
A germline variant in the interferon regulatory factor 4 gene as a novel skin cancer risk locus. Cancer Res (2011) 1.04
Psoriasiform reactions to anti-tumor necrosis factor α therapy. J Clin Rheumatol (2013) 1.04
Increased caffeine intake is associated with reduced risk of basal cell carcinoma of the skin. Cancer Res (2012) 1.03
Update on the management of high-risk squamous cell carcinoma. Semin Cutan Med Surg (2011) 1.03
Smoking and risk of incident psoriasis among women and men in the United States: a combined analysis. Am J Epidemiol (2012) 1.02
SOX2 and nestin expression in human melanoma: an immunohistochemical and experimental study. Exp Dermatol (2011) 1.01
Integrating pathway analysis and genetics of gene expression for genome-wide association study of basal cell carcinoma. Hum Genet (2011) 0.99
Hypercholesterolemia and risk of incident psoriasis and psoriatic arthritis in US women. Arthritis Rheumatol (2014) 0.98
Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth. J Natl Cancer Inst (2010) 0.98
Satisfaction of the uncertainty principle in cancer clinical trials: retrospective cohort analysis. BMJ (2004) 0.98
Host-derived Langerhans cells persist after MHC-matched allografting independent of donor T cells and critically influence the alloresponses mediated by donor lymphocyte infusions. J Immunol (2006) 0.97
Metabolic inhibition of galectin-1-binding carbohydrates accentuates antitumor immunity. J Invest Dermatol (2011) 0.96
Adoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activity. J Clin Invest (2013) 0.96
Aggressive melanoma cells escape from BMP7-mediated autocrine growth inhibition through coordinated Noggin upregulation. Lab Invest (2008) 0.96
Psoriatic alopecia/alopecia areata-like reactions secondary to anti-tumor necrosis factor-α therapy: a novel cause of noncicatricial alopecia. Am J Dermatopathol (2011) 0.96
Use of the parabiotic model in studies of cutaneous wound healing to define the participation of circulating cells. Wound Repair Regen (2010) 0.95